Skip to main content
. 2017 Mar 15;7:201. doi: 10.1038/s41598-017-00143-6

Figure 4.

Figure 4

Identification of post-translational modification (PTM) residues in core histone proteins of bladder cancer cells following heat shock protein 90 inhibitor treatment. The illustration of identified PTM sites on the core histones in 5637 cells in response to AUY922 (A) and ganetespib (B) exposure. The identified PTM sites on the core histones are numbered and highlighted. *Indicates novel histone marks identified in this study. A, acetyl; B, butyryl; C, citrulline; D, dimethyl; G, O-GlcNAcyl; H, 2-hydroxyisobutyryl; M, monomethyl; Ma, malonyl; O, oxidation; P, phosphoryl; Pr, propionyl; S, succinyl; T, trimethyl; U, ubiquityl. (C) An MS/MS spectrum of a tryptic peptide histone H4K20 lysine-butyrylated peptide _RK(bu)VLRDNIQGITKPAIR. (D) An MS/MS spectrum of a tryptic peptide histone H2BK46 lysine-propionylated peptide _VLK(pr)QVHPDTGISSK. (E) An MS/MS spectrum of a tryptic peptide histone H4R23 arginine-trimethylated peptide _KVLR(me3)DNIQGITKPAIR. (F) An MS/MS spectrum of a tryptic peptide histone H3K122 lysine-succinylated peptide _RVTIMPK(su)DIQLAR.